{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:06:03Z","timestamp":1755219963215,"version":"3.43.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.htct.2025.103958","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:18:09Z","timestamp":1753910289000},"page":"103958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A dream or reality: Consideration of \u2018bloodless\u2019 hematopoietic stem cell transplants for Jehovah\u2019s witness patients"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-8958","authenticated-orcid":false,"given":"Michael","family":"MacNeill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7992-4782","authenticated-orcid":false,"given":"Adrienne","family":"Fulford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9391-4204","authenticated-orcid":false,"given":"Uday","family":"Deotare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.htct.2025.103958_bib0001","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/bmt.2015.6","article-title":"Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015","volume":"50","author":"Sureda","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.htct.2025.103958_bib0002","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.transci.2017.05.022","article-title":"Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - literature review and local experience","volume":"56","author":"Elemary","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"6","key":"10.1016\/j.htct.2025.103958_bib0003","first-page":"409","article-title":"A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care","volume":"340","author":"H\u00e9bert","year":"1999","journal-title":"Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med"},{"issue":"3","key":"10.1016\/j.htct.2025.103958_bib0004","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1537-2995.2003.00339.x","article-title":"RBC transfusion requirements after allogeneic marrow transplantation: impact of the before-transplant hb level on transfusion and early survival","volume":"43","author":"Xenocostas","year":"2003","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.htct.2025.103958_bib0005","unstructured":"Watch Tower Bible and Tract Society of Pennsylvania. Service year report of Jehovah's Witnesses worldwide. 2018:1\u20135. https:\/\/www.jw.org\/en\/publications\/books\/2018-service-year-report\/2018-country-territory\/. Last accessed February 19, 2024."},{"issue":"4","key":"10.1016\/j.htct.2025.103958_bib0006","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.0902-4441.2003.00211.x","article-title":"Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat","volume":"72","author":"Laszlo","year":"2004","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.htct.2025.103958_bib0007","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41409-019-0777-9","article-title":"Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients","volume":"55","author":"Beck","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"15","key":"10.1016\/j.htct.2025.103958_bib0008","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1200\/JCO.2014.57.9912","article-title":"Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses","volume":"33","author":"Ford","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.htct.2025.103958_bib0009","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.hemonc.2018.11.003","article-title":"A single-institution experience of performing bloodless transplant in Jehovah's Witness patients","volume":"12","author":"Coltoff","year":"2019","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"2","key":"10.1016\/j.htct.2025.103958_bib0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/cncr.31677","article-title":"Safety and survival outcomes for bloodless transplantation in patients with myeloma","volume":"125","author":"Joseph","year":"2019","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.htct.2025.103958_bib0011","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.bbmt.2019.10.018","article-title":"Hematopoietic stem cell transplantation without the use of blood components by the patient's choice: experience of 2 Brazilian centers","volume":"26","author":"da Silva","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.htct.2025.103958_bib0012","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41409-018-0132-6","article-title":"Bloodless tandem autologous transplant in Jehovah's Witness patients","volume":"53","author":"Khan","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.htct.2025.103958_bib0013","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.bbmt.2019.07.003","article-title":"A review of growth factor support in bloodless autologous hematopoietic stem cell transplant","volume":"25","author":"Zhao","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.htct.2025.103958_bib0014","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/bmt.2016.29","article-title":"Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients","volume":"51","author":"Mazza","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.htct.2025.103958_bib0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12185-008-0055-x","article-title":"Successful autologous peripheral blood stem cell transplantation in a Jehovah's Witness with multiple myeloma: review of literature and recommendations for high-dose chemotherapy without support of allogeneic blood products","volume":"87","author":"Schmitt","year":"2008","journal-title":"Int J Hematol"},{"issue":"10","key":"10.1016\/j.htct.2025.103958_bib0016","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bmt.2008.5","article-title":"SCT in Jehovah's Witnesses: the bloodless transplant","volume":"41","author":"Sloan","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.htct.2025.103958_bib0017","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOH.0000000000000535","article-title":"Transfusion support and alternatives for Jehovah's Witness patients","volume":"26","author":"Crowe","year":"2019","journal-title":"Curr Opin Hematol"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925002263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925002263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:24:09Z","timestamp":1754580249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137925002263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2531137925002263"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2025.103958","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A dream or reality: Consideration of \u2018bloodless\u2019 hematopoietic stem cell transplants for Jehovah\u2019s witness patients","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2025.103958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103958"}}